Q0249 Medicaid Rate by State

Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg

19 state Medicaid programs publish a fee-for-service rate for Q0249 (injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg), ranging from $5.96 in Iowa to $7.57 in Arizona.

Every state, kept current

Every code in every state: the Rates plan

$29 /mo, 7-day free trial

  • Every code on all 51 published schedules
  • Full-schedule CSV export and state network lists
  • Email alerts when a state changes its rates
Start free trial$29/mo after the trial; a trial exports 50-row samples

Or one file, no account: State-Specific Services across 45 states, 1,475 codes.

2026-11-19 edition, standardized by ProviderSignal. Secure checkout by Stripe; download link by email, 5 downloads in 30 days. License · Every file we sell

Publishing states

19

Median % of Medicare

--

Rate range

$5.96 - $7.57

Q0249 rates in every publishing state

  • Arkansas$6.57

    2026

  • Arizona$7.57

    2026

  • District of Columbia$7.57

    Prior auth: not required, 2025

  • Georgia$6.57

    2026

  • Iowa$5.96

    2024

  • Idaho$6.54

    Prior auth: not required, 2025

  • Indiana$6.97

    2023

  • Maryland$7.56

    2021

  • Mississippi$7.57

    2025

  • Montana$7.57

    2026

  • Nebraska$7.56

    2026

  • New Hampshire$6.64

    Prior auth: not required, 2026

  • New Jersey$6.57

    Prior auth: not required, 2026

  • New Mexico$7.57

    2025

  • Oklahoma$7.57

    2026

  • South Carolina$6.53

    2025

  • Utah$7.57

    Prior auth: not required, 2024

  • Virginia$7.56

    2024

  • Vermont$7.19

    Prior auth: required, 2026

Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. A state that lists the code more than one way shows one of its rows here, with its basis: a rental is not a purchase price. "--" in the prior-auth column means the state publishes no PA flag.

Related state-specific services codes

All 52 codes from Q0035 to Q0506 or every state-specific services code by number.

Frequently asked questions

How much does Medicaid pay for Q0249?

19 state Medicaid programs publish a fee-for-service rate for Q0249 (injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg), ranging from $5.96 in Iowa to $7.57 in Arizona. The full table on this page lists every publishing state's current rate.

Which state pays the most for Q0249?

Arizona publishes the highest Medicaid rate for Q0249 at $7.57. Iowa publishes the lowest at $5.96.

Does Q0249 require prior authorization under Medicaid?

1 of the 19 publishing states flag Q0249 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".